Trial: 202009082

A Phase 1b Clinical Trial of Cabozantinib and Abiraterone with Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)

Phase

I

Principal Investigator

Pachynski, Russell

Disease Site

Prostate

Learn more about this study at: clinicaltrials.gov